Welcome to our dedicated page for BCB BANCORP SEC filings (Ticker: BCBP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BCB BANCORP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BCB BANCORP's regulatory disclosures and financial reporting.
BCB Bancorp director James G. Rizzo reported an equity grant of 5,952 shares of common stock on February 10, 2026, awarded at $0 per share. These shares are restricted stock, with one-third vesting each year over a three-year period.
Following this grant, Rizzo directly beneficially owns 68,660 BCB Bancorp shares. He also reports indirect beneficial ownership of 73,554 shares held by an IRA and 3,100 shares held by his spouse's IRA, in addition to his direct holdings.
BCB Bancorp director Joseph Lyga reported an acquisition of 5,952 shares of common stock on February 10, 2026. These are restricted shares, with one-third scheduled to vest each year over a three-year period, meaning the stock becomes fully transferable over time.
After this grant, Lyga directly beneficially owns 187,695 common shares. The filing also notes indirect ownership of 3,386 shares held by a child and 2,985 shares held by a spouse, reflecting family-related holdings in BCB Bancorp.
BCB Bancorp director John Pulomena reported an acquisition of company stock through an equity award. On 02/10/2026, he received 5,952 shares of BCB Bancorp common stock at a price of $0. These are restricted shares, with one-third vesting each year over a three-year period.
Following this grant, Pulomena directly holds 27,052 shares of BCB Bancorp common stock. The filing reflects an equity-based compensation award rather than an open-market purchase.
BCB Bancorp Inc. director Mark D. Hogan reported an acquisition of 5,952 shares of common stock on February 10, 2026 through a stock grant at $0 per share. These shares are restricted stock, with one-third vesting each year over a three-year period.
Following this award, Hogan directly beneficially owns 627,092 shares of BCB Bancorp common stock and indirectly beneficially owns 98,352 shares through an IRA. Shares previously attributed to two children are now reported as having no remaining beneficial ownership interest.
BCB Bancorp director Tara L. French reported a stock award. On 02/10/2026, she acquired 5,952 shares of BCB Bancorp common stock in a grant classified as a restricted stock award at a price of $0 per share. One-third of these restricted shares vest annually over a three-year period. Following this grant, she directly owns 13,142 shares of BCB Bancorp common stock.
BCB Bancorp Inc. director Michael J. Widmer increased his direct holdings through both an award and a purchase of common stock. On February 10, 2026, he acquired 5,952 shares of restricted stock at $0 and bought 2,000 shares in an open-market transaction at $8.40 per share. After these transactions, he directly owned 12,642 shares of BCB Bancorp common stock. The restricted shares vest in three equal annual installments over a three-year period.
BCB Bancorp, Inc., the holding company for BCB Community Bank, filed a report noting it issued a press release with its financial results for the quarter and year ended December 31, 2025. The press release and accompanying financial statements are included as an exhibit.
The company also announced that its board of directors declared a $0.08 per share cash dividend. This dividend will be paid on February 26, 2026 to common shareholders who are on record at the close of business on February 11, 2026.
BCB Bancorp, Inc. reported that its board and management approved a pre-tax write-down of $15.1 million on an isolated cannabis-related real estate owned property, which will be recorded in its fourth quarter 2025 results. This follows a previously disclosed $12.7 million charge-off when the related loan was moved to real estate owned in the third quarter of 2025.
The company also expects its fourth quarter 2025 financial statements to include an additional $16.4 million in net charge-offs, primarily in the commercial and industrial loan portfolio, including a single $6.4 million C&I loan and about $1.4 million tied to Business Express loans. Management states that the bank’s capital position is sufficient to absorb these losses without materially affecting ongoing operations and that it does not expect these charge-offs to require future cash expenditures. The company plans to release full fourth quarter 2025 results on January 30, 2026.
BCB Bancorp, Inc. reported that director Raymond J. Vanaria has retired from its Board of Directors. He informed the company of his decision on January 7, 2026, with his retirement effective as of December 31, 2025. The Board expressed its appreciation for his service to the company and its shareholders.
BCB Bancorp (BCBP) reported Q3 2025 results. Net income was $4.3 million, or $0.22 per diluted share, versus $6.7 million, or $0.36, a year ago. Net interest income was $23.7 million, with a $4.1 million provision for credit losses. For the nine months, the company posted a net loss of $0.5 million compared with $15.4 million in the prior year period, driven by higher credit loss provisions.
Total assets were $3.35 billion and loans, net of a $37.8 million allowance, were $2.79 billion, down from $3.00 billion at December 31, 2024. Deposits totaled $2.69 billion, down from $2.75 billion, while FHLB advances declined to $280.8 million from $455.4 million. Other real estate owned was $20.1 million following transfers from loans. Available-for-sale securities rose in fair value to $115.7 million as unrealized losses narrowed.
Preferred stock additional paid-in capital was $25.2 million. Shares outstanding were 17,228,206 as of November 1, 2025. The company highlighted a distinct cannabis-related loan segment of $69.1 million as of September 30, 2025, down from $103.2 million at year-end 2024.